The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group.
Clin Pharmacokinet.
2019 Jul;58(7):899-910. doi: 10.1007/s40262-018-00734-0. PubMed PMID:
30810947; PubMed Central PMCID:
PMC6658326.
Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review.
Curr Allergy Asthma Rep.
2019 May 14;19(6):32. doi: 10.1007/s11882-019-0864-4. Review. PubMed PMID:
31089823.
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.
Cancer Chemother Pharmacol.
2019 Feb;83(2):349-360. doi: 10.1007/s00280-018-3733-2. Epub 2018 Nov 28. PubMed PMID:
30488179.
Adverse effects of pegaspargase in pediatric patients receiving doses greater than 3,750 IU.
Pediatr Blood Cancer.
2017 Oct;64(10). doi: 10.1002/pbc.26555. Epub 2017 Apr 24. PubMed PMID:
28436558.
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium.
Cancer Chemother Pharmacol.
2017 Jan;79(1):181-187. doi: 10.1007/s00280-016-3220-6. Epub 2016 Dec 28. PubMed PMID:
28032129; PubMed Central PMCID:
PMC5225209.
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.
Hepatology.
2017 Jan;65(1):104-121. doi: 10.1002/hep.28888. Epub 2016 Nov 29. PubMed PMID:
27775819.
Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity.
J Pediatr Hematol Oncol.
2017 Jan;39(1):72-76. doi: 10.1097/MPH.0000000000000696. PubMed PMID:
27820134.
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.
J Hepatol.
2016 Aug;65(2):325-33. doi: 10.1016/j.jhep.2016.04.009. Epub 2016 Apr 23. PubMed PMID:
27117591; PubMed Central PMCID:
PMC5668139.
Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children's Hospital.
Pediatr Transplant.
2016 Jun;20(4):515-22. doi: 10.1111/petr.12699. Epub 2016 Mar 27. PubMed PMID:
27018238.
Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy.
J Pediatr Surg.
2016 Apr;51(4):525-9. doi: 10.1016/j.jpedsurg.2015.10.053. Epub 2015 Oct 24. PubMed PMID:
26607968.
Reply to: No correlation between estimated and actual glomerular filtration rates in pediatric oncology patients.
Pediatr Blood Cancer.
2015 Jul;62(7):1300. doi: 10.1002/pbc.25491. Epub 2015 Mar 16. PubMed PMID:
25777466.
Focal nodular hyperplasia in children: an institutional experience with review of the literature.
J Pediatr Surg.
2015 Mar;50(3):382-7. doi: 10.1016/j.jpedsurg.2014.06.016. Epub 2014 Aug 27. Review. PubMed PMID:
25746693.
Agreement among measurements and estimations of glomerular filtration in children with cancer.
Pediatr Blood Cancer.
2015 Jan;62(1):80-4. doi: 10.1002/pbc.25194. Epub 2014 Sep 27. PubMed PMID:
25263332.
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report.
Neuro Oncol.
2014 Dec;16(12):1661-8. doi: 10.1093/neuonc/nou103. Epub 2014 Jun 7. PubMed PMID:
24908656; PubMed Central PMCID:
PMC4232081.
Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.
Pediatr Radiol.
2014 Oct;44(10):1275-80. doi: 10.1007/s00247-014-3000-6. Epub 2014 May 18. PubMed PMID:
24839140.
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).
Clin Cancer Res.
2013 Dec 1;19(23):6578-84. doi: 10.1158/1078-0432.CCR-13-1117. Epub 2013 Oct 4. PubMed PMID:
24097866; PubMed Central PMCID:
PMC4079262.
Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas.
Neuro Oncol.
2013 Jun;15(6):759-66. doi: 10.1093/neuonc/nos315. Epub 2013 Apr 16. PubMed PMID:
23592571; PubMed Central PMCID:
PMC3661085.
Extrarenal Wilms tumor: a case report and review of the literature.
J Pediatr Surg.
2013 Jun;48(6):E33-5. doi: 10.1016/j.jpedsurg.2013.04.021. Review. PubMed PMID:
23845655.
Unusually early presentation of small-bowel adenocarcinoma in a patient with Peutz-Jeghers syndrome.
J Pediatr Hematol Oncol.
2013 May;35(4):323-8. doi: 10.1097/MPH.0b013e318282db11. PubMed PMID:
23426006; PubMed Central PMCID:
PMC3708690.
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).
Pediatr Blood Cancer.
2013 Mar;60(3):390-5. doi: 10.1002/pbc.24271. Epub 2012 Aug 9. PubMed PMID:
22887890; PubMed Central PMCID:
PMC3511610.
Vascular-targeted photothermal therapy of an orthotopic murine glioma model.
Nanomedicine (Lond).
2012 Aug;7(8):1133-48. doi: 10.2217/nnm.11.189. Epub 2012 May 14. PubMed PMID:
22583571; PubMed Central PMCID:
PMC5375028.
Renal and hepatic tumors in the neonatal period.
Semin Fetal Neonatal Med.
2012 Aug;17(4):216-221. doi: 10.1016/j.siny.2012.04.002. Epub 2012 May 16. Review. PubMed PMID:
22595862.
Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma.
Pediatr Blood Cancer.
2012 Jun;58(6):1006-7. doi: 10.1002/pbc.24045. Epub 2011 Dec 19. PubMed PMID:
22183980.
Targeted therapy in bone and soft tissue sarcoma in children and adolescents.
Curr Oncol Rep.
2012 Apr;14(2):197-205. doi: 10.1007/s11912-012-0223-2. Review. PubMed PMID:
22302601.
Nanoshell-mediated photothermal therapy improves survival in a murine glioma model.
J Neurooncol.
2011 Aug;104(1):55-63. doi: 10.1007/s11060-010-0470-8. Epub 2010 Nov 26. PubMed PMID:
21110217; PubMed Central PMCID:
PMC3710584.
Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates.
Cancer Chemother Pharmacol.
2011 Apr;67(4):809-12. doi: 10.1007/s00280-010-1380-3. Epub 2010 Jun 19. PubMed PMID:
20563581.
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report.
Clin Cancer Res.
2011 Feb 1;17(3):589-97. doi: 10.1158/1078-0432.CCR-10-0738. Epub 2010 Nov 29. PubMed PMID:
21115653; PubMed Central PMCID:
PMC3064523.
Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates.
Cancer Chemother Pharmacol.
2010 Feb;65(3):419-25. doi: 10.1007/s00280-009-1044-3. Epub 2009 Jun 13. PubMed PMID:
19526240; PubMed Central PMCID:
PMC2953793.
Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.
Cancer Chemother Pharmacol.
2009 Jul;64(2):243-51. doi: 10.1007/s00280-008-0854-z. Epub 2008 Nov 20. PubMed PMID:
19020877.
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates.
Cancer Chemother Pharmacol.
2009 Jul;64(2):335-40. doi: 10.1007/s00280-008-0875-7. Epub 2008 Nov 29. PubMed PMID:
19043710.
Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis.
Pediatr Blood Cancer.
2009 May;52(5):621-5. doi: 10.1002/pbc.21838. PubMed PMID:
19137570; PubMed Central PMCID:
PMC3660724.
Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
Cancer Chemother Pharmacol.
2009 Jan;63(2):229-38. doi: 10.1007/s00280-008-0730-x. Epub 2008 Apr 9. PubMed PMID:
18398615.
Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group.
Cancer Chemother Pharmacol.
2008 Nov;62(6):1027-37. doi: 10.1007/s00280-008-0692-z. Epub 2008 Feb 16. PubMed PMID:
18278496.
Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.
Pediatr Blood Cancer.
2008 Oct;51(4):504-8. doi: 10.1002/pbc.21638. PubMed PMID:
18561175; PubMed Central PMCID:
PMC4063282.
Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.
Cancer Chemother Pharmacol.
2008 Apr;61(4):647-52. doi: 10.1007/s00280-007-0519-3. Epub 2007 May 31. PubMed PMID:
17541590.
Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines.
J Neurooncol.
2008 Jan;86(2):165-72. doi: 10.1007/s11060-007-9467-3. Epub 2007 Sep 6. PubMed PMID:
17805488.
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
J Clin Oncol.
2007 Nov 1;25(31):4922-8. doi: 10.1200/JCO.2007.12.0667. PubMed PMID:
17971589; PubMed Central PMCID:
PMC6684202.
Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.
Cancer Chemother Pharmacol.
2007 May;59(6):847-53. doi: 10.1007/s00280-006-0388-1. Epub 2006 Nov 29. PubMed PMID:
17136402.
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.
Clin Cancer Res.
2007 Mar 1;13(5):1516-22. doi: 10.1158/1078-0432.CCR-06-2173. PubMed PMID:
17332297; NIHMSID:NIHMS83557.
Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates.
Cancer Chemother Pharmacol.
2007 Mar;59(4):461-6. doi: 10.1007/s00280-006-0285-7. Epub 2006 Jul 20. PubMed PMID:
16855840.
Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study.
Clin Cancer Res.
2004 Aug 1;10(15):5072-5. doi: 10.1158/1078-0432.CCR-03-0123. PubMed PMID:
15297409.
Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates.
Cancer Chemother Pharmacol.
2004 Jul;54(1):85-8. doi: 10.1007/s00280-004-0766-5. Epub 2004 Mar 23. PubMed PMID:
15042312.
Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates.
Cancer Chemother Pharmacol.
2004 Jun;53(6):527-32. doi: 10.1007/s00280-004-0765-6. Epub 2004 Mar 2. PubMed PMID:
14997342.
Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates.
Clin Cancer Res.
2004 Apr 1;10(7):2525-9. doi: 10.1158/1078-0432.ccr-03-0155. PubMed PMID:
15073132.
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer.
Cancer Chemother Pharmacol.
2003 Nov;52(5):417-23. doi: 10.1007/s00280-003-0674-0. Epub 2003 Jul 15. PubMed PMID:
12879279.
What would you like to do?